Left untreated, obstructive sleep apnea (OSA) can have short- and long-term effects on your brain, from memory and learning to cognitive functions.

By Hugo Francisco de Souza New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing ...

Severe or decompensated obstructive sleep apnoea syndrome (OSAS) was significantly associated with functional hypogonadism in men with severe obesity. Continuous positive airway pressure (CPAP) ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

Thinking about using a CPAP machine to quell sleep apnea? It's not necessarily a good idea for everyone, a new evidence review argues. This common treatment for sleep apnea might increase some folks' ...

Sleep apnea affects more than 30 million Americans, making it one of the most prevalent sleep disorders in the United States. Continuous Positive Airway Pressure (CPAP) therapy has emerged as the ...

Over decades, the government has spent billions on disability payments for veterans with sleep apnea, a common condition that interrupts breathing during sleep and causes fatigue. In early 2022, ...

Twenty-five million—that’s the number of adults in the U.S. suffering from Obstructive Sleep Apnea (OSA), a condition that can range from mild difficulty breathing during sleep to a fatal condition, ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...